New Key Statistics Module, Z-Score and F-Score
NAS:KROS Key Ratios
| Market Cap $ M | 2,114.74 |
| Enterprise Value $ M | 1,662.43 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.70 |
| Price/Sales | 6,843.75 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -5.13 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -96.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -9.31 |
| EV-to-EBITDA | -9.36 |
| PEG | -- |
| Shares Outstanding M | 37.52 |
| Net Margin (%) | -62,012.55 |
| Operating Margin % | -68,729.52 |
| Pre-tax Margin (%) | -62,012.55 |
| Quick Ratio | 20.37 |
| Current Ratio | 20.37 |
| ROA % (ttm) | -42.15 |
| ROE % (ttm) | -45.94 |
| ROIC % (ttm) | -610.08 |
| Dividend Yield % | -- |
| Altman Z-Score | 34.56 |
KROS Number of Guru Trades
KROS Volume of Guru Trades
Gurus Latest Trades with NAS:KROS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KROS is held by these investors
Total 1
Keros Therapeutics Inc Insider Transactions
No Available Data
News about NAS:KROS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers